Mag.rer.nat. Hannes Schleifer Molecular Mechanisms involved in TRPC/NFAT-mediated Gene Expression Dissertation zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften an der Naturwissenschaftlichen Fakultät der Karl-Franzens-Universität Graz Betreut von ao.Univ.-Prof. Mag.pharm. Dr. Klaus Groschner Durchgeführt am Institut für Pharmazeutische Wissenschaften Department Pharmakologie und Toxikologie der Karl-Franzens-Universität Graz von Oktober 2007 bis März 2012 eingereicht 2012
109
Embed
Molecular Mechanisms involved in TRPC/NFAT-mediated Gene ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Mag.rer.nat. Hannes Schleifer
Molecular Mechanisms involved in
TRPC/NFAT-mediated Gene Expression
Dissertation
zur Erlangung des akademischen Grades eines
Doktors der Naturwissenschaften
an der Naturwissenschaftlichen Fakultät
der Karl-Franzens-Universität Graz
Betreut von ao.Univ.-Prof. Mag.pharm. Dr. Klaus Groschner
Durchgeführt am
Institut für Pharmazeutische Wissenschaften
Department Pharmakologie und Toxikologie
der Karl-Franzens-Universität Graz
von Oktober 2007 bis März 2012
eingereicht 2012
Mein besonderer Dank gilt …
… ao.Univ.-Prof. Mag. Dr. Klaus Groschner, vor allem für die kompetente Betreuung, die
Bereitstellung des Themas und die wissenschaftliche Anleitung.
… Herrn o.Univ.-Prof. Dr. Bernhard-Michael Mayer für die Bereitstellung des Arbeitsplatzes.
… Petra, Annarita, „Mike“, Renate, „Michi S.“, „Michi L.“, Sarah, Zora, Bernhard sowie allen
nicht genannten Kolleginnen und Kollegen der Arbeitsgruppe für Ionenkanal-Pharmakologie
und -Physiologie für ihre Unterstützung, Ratschläge und Hilfe, anregende Diskussionen, ihre
Motivation und die gute Zusammenarbeit.
… allen weiteren Institutsangehörigen, Kolleginnen und Kollegen für das gute Arbeitsklima.
… dem FWF für die Finanzierung meiner Dissertation (Projekt P21925-B19 & P21118-B09).
… all meinen Freunden und jenen Menschen, die das Leben in Graz und an allen anderen
Orten und Gelegenheiten - besonders auch abseits der Universität - lebenswert gemacht
haben.
sowie vor allem
… meiner Familie für den bedingungslosen Rückhalt und die Unterstützung während meiner
Ausbildung
und
… meiner Partnerin Birgit für unzählige wunderschöne Stunden.
No, try not. Do or do not.
There is no try.
(Yoda in Star Wars Episode V – The Empire Strikes Back)
activated gene expression. Ca2+ entry into cells is an important cellular signalling process,
which governs gene transcription, generally referred to as Ca2+/transcription coupling.
Although a link between TRPC3 function and NFAT translocation along with an interaction of
the channel with NFAT-binding proteins has recently been proposed, the molecular
mechanisms involved in TRPC3-mediated Ca2+/transcription coupling, specifically the role of
TRPC3 permeation, dynamic protein-protein interactions with other channels or reversible
protein modifications remain still unclear.
To shed light on these aspects, I set out to generate channel mutants that specifically lack
certain signalling properties and to develop tools for selective pharmacological modulation
of TRPC3 function. The TRPC3 mutants were characterized in a native cellular setting of HL-1
cardiac myocytes and RBL-2H3 mast cells, employing a combined approach of Fura2-Ca2+-
imaging, conventional fluorescence and TIRF microscopy as well as patch clamp
experiments. The mutations were designed based on a computational homology model of
the TRPC3 channel structure and were intended to target the channels selectivity filter as
well as its ability to dynamically associate with scaffold proteins and the Ca2+ sensor CaN.
This approach was expected to provide new insights into:
1. The pore structure and molecular determinants of TRPC3 channel functions
2. The impact of selective block or modulation of TRPC3 and Orai1 function on signalling
events downstream of Ca2+ entry through these channels and
3. The crosstalk of TRPC3 with STIM1/Orai1 SOCE-phenomena and contribution of the
TRPC protein in Ca2+/transcription coupling.
The experiments and conclusions from this work are presented in form of published or for
publication submitted and prepared manuscripts.
20
Applied methods
The following experimental methods were applied in this thesis work. Detailed information
on the procedures is given within the included manuscripts (Poteser et al., 2011) (Schleifer
et al., 2012 - British Journal of Pharmacology - submitted, Schleifer et al., 2012 - in
preparation):
Standard molecular biology techniques, PCR, molecular cloning, site directed
mutagenesis, sequencing and preparation of plasmid DNA for cell culture,
Heterologous expression of proteins in e.coli,
Cell culture and handling of cell lines, mainly HEK-293, RBL-2H3 and HL-1 cells,
including normal passaging and transfection by lipofection or electroporation to
heterologously express proteins,
Application of microscopy techniques, specifically fluorescence and TIRF microscopy
including data evaluation,
Cellular calcium imaging using Fura2 applying receptor-activation and store-depletion
protocols including large scale data analysis and
Initial generation of a TRPC3 homology model and further bioinformatic
methodology (sequence alignments, phylogenetic and homology analysis …) for in-
silico studies of TRPC3 pore properties.
21
Results
PKC-dependent coupling of calcium permeation through transient
receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-
1 myocytes.
Proc Natl Acad Sci USA 108(26): 10556-10561
Michael Potesera, Hannes Schleifera, Michaela Lichteneggera, Michaela Schernthanera,
Thomas Stocknerb, C. Oliver Kappec, Toma N. Glasnovc, Christoph Romanind and Klaus
Groschnera
a
Institute of Pharmaceutical Sciences, University of Graz, 8010 Graz, Austria;
b Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria;
c Institute of Chemistry, University of Graz, 8010 Graz, Austria and
d Institute of Biophysics, University of Linz, 4040 Linz, Austria
PKC-dependent coupling of calcium permeationthrough transient receptor potential canonical 3(TRPC3) to calcineurin signaling in HL-1 myocytesMichael Potesera, Hannes Schleifera, Michaela Lichteneggera, Michaela Schernthanera, Thomas Stocknerb,C. Oliver Kappec, Toma N. Glasnovc, Christoph Romanind, and Klaus Groschnera,1
aInstitute of Pharmaceutical Sciences, University of Graz, 8010 Graz, Austria; bInstitute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria;cInstitute of Chemistry, University of Graz, 8010 Graz, Austria; and dInstitute of Biophysics, University of Linz, 4040 Linz, Austria
Edited* by Lutz Birnbaumer, National Institute of Environmental Health Sciences, Research Triangle Park, NC, and approved May 17, 2011 (received for reviewApril 21, 2011)
Cardiac transient receptor potential canonical (TRPC) channels arecrucial upstream components of Ca2+/calcineurin/nuclear factor ofactivated T cells (NFAT) signaling, thereby controlling cardiac tran-scriptional programs. The linkage between TRPC-mediated Ca2+ sig-nals and NFAT activity is still incompletely understood. TRPCconductances may govern calcineurin activity and NFAT transloca-tion by supplying Ca2+ either directly through the TRPC pore intoa regulatory microdomain or indirectly via promotion of voltage-dependent Ca2+ entry. Here, we show that a point mutation in theTRPC3 selectivity filter (E630Q), which disrupts Ca2+ permeabilitybut preserves monovalent permeation, abrogates agonist-inducedNFAT signaling in HEK293 cells as well as in murine HL-1 atrial myo-cytes. The E630Q mutation fully retains the ability to convert phos-pholipase C-linked stimuli into L-type (CaV1.2) channel-mediatedCa2+ entry in HL-1 cells, thereby generating a dihydropyridine-sensitive Ca2+ signal that is isolated from the NFAT pathway. Pre-vention of PKC-dependentmodulation of TRPC3 by either inhibitionof cellular kinase activity or mutation of a critical phosphorylationsite in TRPC3 (T573A), which disrupts targeting of calcineurin intothe channel complex, converts cardiac TRPC3-mediated Ca2+ signal-ing into a transcriptionally silent mode. Thus, we demonstrate a di-chotomy of TRPC-mediated Ca2+ signaling in the heart constitutingtwo distinct pathways that are differentially linked to gene tran-scription. Coupling of TRPC3 activity to NFAT translocation requiresmicrodomain Ca2+ signaling by PKC-modified TRPC3 complexes.Our results identify TRPC3 as a pivotal signaling gateway in Ca2+-dependent control of cardiac gene expression.
As a universal and versatile second messenger, calcium (Ca2+)governs a multitude of cellular effector functions in the
heart including transcriptional programs and cellular remodelingprocesses (1). Coordinated control of cardiac functions by Ca2+ re-quires efficient segregation of Ca2+ signals into regulatory micro-domains, resulting in specificity of coupling between Ca2+ sourcesand Ca2+-dependent effector systems. So far, the molecular com-position and architecture of Ca2+ signaling microdomains forcontrol of cardiac transcriptional programs is incompletely un-derstood. Cation channels of the transient receptor potential ca-nonical (TRPC) family constitute a ubiquitous signal transductionmachinery for Ca2+ entry and have recently been identified as ionchannels that trigger pathophysiological activation of nuclear factorof activated T-cell (NFAT)-mediated gene transcription and hy-pertrophic remodeling in the heart (2–4). TRPC proteins formCa2+ permeable plasma membrane channels that are typically ac-tivated in response to hormonal stimuli linked to phospholipaseC signaling (5). These channels lack, or display only modest, se-lectivity for Ca2+ over monovalent cation (6) and are able to gen-erate increases in cytosolic Ca2+ viamultiplemechanisms includingindirect initiation ofCa2+ entry via voltage-gatedCa2+ channels (7)or the sodium calcium exchanger (NCX) because of modulation of
membrane potential and/or local Na+ gradients (8). TRPC chan-nels are expected to contribute divergently to Ca2+ signaling innonexcitable and in excitable cells, which provide a certain reper-toire of voltage-dependent Ca2+ transport systems.TRPC3 is a lipid-regulated member of the TRPC subfamily and
a potential player in cardiac pathophysiology (9). For homomericTRPC3 channels, a Ca2+/Na+ permeability ratio of ≈1.6 wasdetermined (10) and functional crosstalk of TRPC3 channels withcardiac voltage-gated Ca2+ channels and NCX1 has been sug-gested (7, 11). Representing a typical nonselective cation channel,TRPC3 controls cellular processes by either Ca2+ permeationthrough its pore and generation of a local Ca2+ signal at the TRPchannel signalplex or by remote effects on voltage-gated Ca2+
channels or electrogenic transporters. According to a paradigm ofcardiac (patho)physiology, beat-to-beat Ca2+ cycling (E-C cou-pling) in the heart is separated from Ca2+ signaling events thatcontrol gene expression (12). Interestingly, TRPC3 has beensuggested to govern gene transcription by mechanisms involvinga linkage to voltage-dependent Ca2+ entry (7), which is also es-sential for E-C coupling. However, the Ca2+ entry mechanism,which links cardiac TRPC3 activity to gene expression is elusiveand it is unclear whether nonselective TRPC channels serve asdual Ca2+ signaling units that control segregated Ca2+ pools. Toaddress these questions, we set out to engineer the TRPC3 cationpermeation pathway and generated a single point mutation(E630Q) that lacks divalent- but retains monovalent permeabilityand, thus, the potential to control voltage-dependent Ca2+ entry.This mutant was found capable of functional coupling to cardiacCaV1.2 signaling but not to NFAT activation. We present evi-dence for a tight link between TRPC3 channel activity and NFATnuclear translocation based on Ca2+ permeation through theTRPC3 pore, generating a local Ca2+ signaling event that issensed by the downstream effector calcineurin (CaN), which istargeted to cardiac TRPC3 channels. Moreover, we demonstratethat protein kinase C-dependent modulation of the channelenables switching between transcriptionally active and inactiveTRPC3-signaling modes.
Results and DiscussionIdentification of E630 as a Critical Residue in the TRPC3 SelectivityFilter. In an attempt to obtain TRPC mutants with altered ionselectivity, we initially generated a structural model of the TRPC3pore region by using a recently developed alignment strategy (13)
Author contributions: M.P. and K.G. designed research; M.P., H.S., M.L., M.S., and T.S.performed research; C.O.K., T.N.G., and C.R. contributed new reagents/analytic tools;M.P., H.S., M.L., M.S., and T.S. analyzed data; and M.P., H.S., and K.G. wrote the paper.
The authors declare no conflict of interest.
*This Direct Submission article had a prearranged editor.
Freely available online through the PNAS open access option.1To whom correspondence should be addressed. E-mail: [email protected].
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1106183108/-/DCSupplemental.
and structure information available for KcsA as well as a Kv1.2-Kv1.3 chimeric pore. Our hypothetical pore model is illustrated inFig. S1A along with the sequence comparison of TRPC3 andtemplate pore structures (Fig. S1B). Three of the five negativeresidues were predicted to be accessible and exposed to the per-meation pathway. According to our molecular model, only oneglutamate (E630) was localized within the central part of thepermeation pathway, whereas the other two residues (E616 andD639) were predicted as part of the extracellular vestibule. Mu-tagenesis and functional analysis confirmed a critical role of thecentral glutamate in position 630. Charge inversion (E630K)yielded a nonfunctional channel (Fig. S2), whereas neutralization(E630Q) produced a channel that displayed moderately alteredcurrent to voltage (I-V) relation in normal extracellular (Na+ plusCa2+ containing; Fig. 1 A and C) solution with a relative increasein the conductance at neutral potential. The I-V relation of theTRPC3-E630Q mutant was virtually insensitive to changes inextracellular Ca2+ (Fig. S3). Inspection of I-V relations with Ca2+as the sole extracellular cationic charge carrier and BAPTA in thepipette solution to eliminate indirect, Ca2+-mediated currentsrevealed that the E630Q mutation profoundly reduced Ca2+permeation although the channel complex (Fig. 2 B and D). In-ward currents were essentially small or lacking with Ca2+ asa charge carrier even at large hyperpolarizing potentials, and re-versal potentials were difficult to determine in most experiments.Nonetheless, from six experiments a mean of −79.6 ± 6.3 mV wascalculated, demonstrating a substantial shift in reversal potentialcompared with wild-type channels (1.9 ± 1.4; n = 7). The Ca2+/Cs+ permeability ratio was reduced from 4.2 to less than 0.02 inthe mutant. Thus, our experiments identified a key amino acidwithin the cation permeation structure of TRPC3. The negativecharge in position 630 is apparently essential for divalent per-meation but not for transition of monovalent cations through theTRPC3 pore. Our finding is in line with previous reports on therole of negatively charged residues in Ca2+ transition throughTRP pores (14–17) and, specifically, with a prediction of criticalresidues in the TRPC selectivity filter obtained by Liu et al. in astudy with the prototypical Drosophila TRP channel (14). It is ofnote that the identified negatively charged residue is conservedin the TRPC3/6/7 subfamily but absent in more distant relatives ofTRPC3. Therefore, Ca2+ permeation in within the TRPC familyof cation channels may involve distinctly different molecular
mechanisms. Our results support the notion that monovalent anddivalent permeation through nonselective TRP cation channelsmay involve separate, specific interaction sites within the pore,which combine to a “nonselective” pathway that conducts bothtypes of charge carriers. Based on our observation that a singlepoint mutation within the TRPC3 pore causes specific eliminationof Ca2+ permeation, we set out to use this genetically engineeredcation channel to explore the cellular impact of the TRPC3-mediated monovalent conductance and to identify downstreamsignaling pathways that are specifically linked to either themonovalent transport or to Ca2+ entry through the channel pore.Because the TRPC monovalent conductance is considered ofparticular importance in excitable cells, and because recent studieshave demonstrated the relevance of TRPC channels in cardiacpathophysiology (2, 4, 7, 18) we focused on the cardiac system,using the HL-1 murine atrial cell line. Initially, we compared basicproperties of TRPC3 signaling in HL-1 cells with those in thewell characterized electrically nonexcitable HEK293 system.
TRPC3 Mediates Agonist-Induced Ca2+ Signals in HEK293 and HL-1Cells by Divergent Mechanisms. So far, the relative contributionof direct Ca2+ permeation through the TRPC3 pore and indirectmechanisms involving TRPC-mediated changes in membranepotential and voltage-dependent signaling partners such as NCX1has not been evaluated in HEK293 cells. Expression levels ofendogenous voltage-gated Ca2+ channels are below the detectionthreshold, and NCX1 expression is typically moderate to low.Hence, only a minor fraction of the TRPC3-mediated Ca2+ signalis expected to involve indirect mechanisms in HEK293. Pharma-cological characterization of the TRPC3-mediated Ca2+ entrypathway in HEK293 and HL-1 cells, determined by using a clas-sical Ca2+ readdition protocol, revealed that global Ca2+ signalswere based on distinctly different mechanisms (Fig. S4). Elec-trophysiological experiments confirmed that TRPC3 channelswere active when Ca2+ was elevated after activation by agonistadministration in Ca2+-free solution (Fig. S5). TRPC3 over-expressing HEK293 as well as HL-1 displayed Ca2+ entry thatwas highly sensitive to inhibition by the TRPC3 blocker Pyr3 (19).KB-R7943, an inhibitor of NCX reverse mode operation, sup-pressed Ca2+ entry only moderately in HEK293 cells and lackedinhibitory effects in HL-1 cells. Block of voltage-gated, L-typeCa2+ channels by nifedipine strongly suppressed Ca2+ entryinto endothelin-stimulated HL-1 cells but had no effect on theCa2+ signal in HEK293 cells (Fig. S4). These results indicate thatTRPC3 is effectively linked to voltage-gated Ca2+ signaling incardiac cells and are able to produce large global cytosolic Ca2+rises via promotion of Ca2+ entry through CaV1.2 channels. Theobserved lack of NCX-mediated Ca2+ entry into HL-1 cells maybe explained by predominant forward mode operation in thesecardiac cells, based on a tight functional coupling to voltage-gatedCa2+ entry channels as well as more negative membrane poten-tials compared with HEK293 cells. Thus, HL-1 myocytes repre-sent an electrically excitable cell type that displays functionalcross-talk and signaling partnership between nonselective TRPCconductances and voltage-gated Ca2+ channels. Thereby, TRPC3signaling in HL-1 cells is distinctly different from that in thenonelectrically excitable HEK293 cell system.As a next step, we aimed to delineate the cellular role of direct
Ca2+ permeation through TRPC3 channels in these cells by char-acterizing coupling between Ca2+ entry and the NFAT down-stream effector system for wild type and poremutants (E630Q andE630K) of TRPC3.
Ca2+ Permeation Through the Pore of TRPC3 Channels Is Essential forActivation of the NFAT Pathway. Carbachol-induced Ca2+ entry aswell as NFAT translocation was strongly reduced by expression ofeither the Ca2+ permeation-deficient mutant (E630Q) or a pore-deadmutant (E630K) (Fig. 2). Basal Ca2+ entry into nonstimulatedcells was reduced when expressing either of the TRPC3 poremutants to the level of vector-transfected controls (Fig. 2B). Asexpected from the proposed NCX1-mediated Ca2+ entry contri-
Fig. 1. Neutralization of E630 in TRPC3 (E630Q) eliminates Ca2+ but notmonovalent permeability. Representative ramp protocol recordings fromHEK293 cells transfected by either TRPC3-WT (A and B) or the mutantchannel E630Q (C and D) in the presence of 140 mM extracellular Na+ and2 mM Ca2+ (A and C), or in absence of extracellular Na+ and presence of10 mM Ca2+ using 10 mM BAPTA in the pipette solution (B and D), before(black) and after stimulation with 100 μM carbachol (+CCh, red).
Poteser et al. PNAS | June 28, 2011 | vol. 108 | no. 26 | 10557
bution,TRPC3-E630Qdidnot fully eliminate theCa2+entry signal.Ca2+ entry into cells expressing TRPC3-E630Q remained signifi-cantly higher than in cells transfected to express TRPC3-E630K.Nonetheless, NFAT translocation in HEK293 cells was completelysuppressed with either pore mutation of TRPC3 (Fig. 2 C and D).This finding indicated that Ca2+ permeation through the pore isessential to initiate NFAT translocation, whereas indirect NCX-mediated signaling was barely involved because the NCX inhibitorKB-R7943 (5 μM) failed to prevent NFAT translocation (Fig. S6).A possible dual Ca2+ signaling function of TRPC3 was further
investigated in the electrically excitable cardiac HL-1 cell line. Asillustrated in Fig. 3, Ca2+ entry into endothelin-stimulated cellswas slightly enhanced compared with vector-transfected controls(Fig. 3A) by expression of either wild-type TRPC3 (Fig. 3B) orTRPC3-E630Q (Fig. 3C) but reduced down to basal (non-stimulated) level with TRPC3-E630K (Fig. 3D). Expression ofwild-type TRPC3 (Fig. 3B) or TRPC3-E630Q (Fig. 3C) generated aCa2+ signal that was mainly based on voltage-gated CaV1.2channels as evident by its sensitivity to nifedipine (3 μM). In clearcontrast to the observed Ca2+ signals, cells expressing TRPC3-E630Q lacked endothelin-stimulated NFAT translocation (Fig.3C). Thus, the TRPC3mutant with impaired divalent conductance(E630Q) is able to initiate a large global Ca2+ signal via promotionof voltage-gated Ca2+ entry, but this signal is not translated intoNFATactivation. Importantly, even endogenous TRPC3 channelsappear sufficient to exert a significant impact on NFAT trans-location as evident from vector-transfected controls displayinghigher translocation than cells expression the pore-dead domi-nant-negative E630K mutant. It is of note that, in contrast toHEK293 cells, NFAT translocation in HL-1 cells was not signifi-cantly promoted in response to depletion of intracellular storeswith thapsigargin (Fig. S7), indicating that the channels involved inNFAT signaling of HL-1 are not classical store-operated Ca2+
entry channels. Opening of TRPC3 channels resulted in NFATactivation, but also generation of an additional intracellular Ca2+signal mediated by voltage-gated Ca2+ channels that was fairlywell segregated from the NFAT pathway. Notably, TRPC3-mediated NFAT activation can occur at barely detectable globalCa2+ changes such as in the presence of nifedipine (3 μM) incontrol cells or cells overexpressing TRPC3 (Fig. 3 A and B),therefore we hypothesized that the triggering Ca2+ elevation islikely to take place in a restricted signaling microdomain at theTRPC3 channel complex, containing essential downstream sig-naling components such as calmodulin and calcineurin (CaN) toallow specific transduction of this local Ca2+ signal. Indeed, directassociation of TRPC3 with CaN have been demonstrated (20, 21)
and the existence of a dynamic TRPC/CaN signaling complexeshave been proposed.
Coupling of Cardiac TRPC3 Signaling to Activation of the NFATPathway Involves PKC-Dependent Phosphorylation. Previous inves-tigations demonstrated assembly of CaN along with immuno-phyllins (FKBP12) into TRPC6 signalplexes and dependency ofthis process on protein kinase C-mediated phosphorylation (21).PKC-mediated phosphorylation of TRPC3 appears essential forboth recruitment of CaN into TRPC complexes and inhibitoryregulation (22, 23). This result prompted us to hypothesize thatsuppression of PKC phosphorylation may disrupt the functionalTRPC3/CaN signaling unit without preventing channel function.Consequently, we set out to test whether TRPC3 linkage toNFATnuclear translocation depends on regulation of the channelcomplex by PKC. To suppress TRPC3 phosphorylation by PKCisoenzymes, we performed experiments with GF109203X, a com-pound that inhibits conventional PKC isoforms including PKC-γ,as one essential player in the control of TRPC3 channels (23).Because CaN has been shown to associate with TRPC3/6 channelsin a manner dependent on phosphorylation by PKC (21), wespeculated that prevention of PKC phosphorylation may disruptTRPC/CaN complexes. Indeed, immunoprecipitation experi-ments in HEK293 cells confirmed that the PKC inhibitor preventsassociation of CaN into TRPC3 complexes along with reductionof threonine phosphorylation of the channel protein (Fig. 4).Alternatively, a mutant that is defective in PKC-γ–mediated in-hibitory modulation, i.e., T573A corresponding to the murineTRPC3-moonwalker (Mwk) mutation, was expressed in HEK293and HL-1 cells. It is of note that overexpression of the phos-phorylation-deficient TRPC3-Mwk by itself was barely toleratedby the cells, presumably due to a gain in function leading to Ca2+
overload. Therefore, we transfected cells to overexpress theT573Amutant along with wild-type TRPC3 (DNA ratio 3:1). Thistransfection resulted in a heteromeric TRPC3 conductance largerthan that generated by wild-type TRPC3 alone (Fig. S8) but es-sentially tolerated by the host cells. The derived heteromersappeared correctly targeted into the membrane as indicated byfluorescence microscopy. Interestingly, currents through TRPC3-Mwk/TRPC3-WT channels were rather stable during continuousagonist stimulation, most likely due to lack of inhibitory regula-tion of the channels by PKC and recordings in Na+-free extra-cellular solution confirmed Ca2+ permeability of the channels.Either treatment of cells expressing TRPC3-WT with
GF109203X (2 μM) or transfection of cells with TRPC3-Mwk/TRPC3-WT produced a similar cellular phenotype, displaying
B C DA
Fig. 2. Receptor-stimulated Ca2+ influx as well as NFAT translocation are impaired in HEK293 cells expressing the Ca2+ impermeable TRPC3-E630Q or theimpermeant TRPC3-E630K, compared with cells expressing wild-type TRPC3. (A) Representative traces of fura-2 Ca2+-imaging experiments. Cells were stim-ulated by 100 μM carbachol (arrow). (B) Mean Δ ratio values (± SEM, n > 40) derived from fura-2 Ca2+-imaging. Black bars indicate the basal (unstimulated)Ca2+ entry at indicated transfections. (C) Mean nuclear/cytosol fluorescence intensity ratio (± SEM, n > 11) of HEK293 cells expressing GFP-NFAT and therespective channel protein after stimulation and application of the same protocol as used in fura-2 experiments. Black bar (basal) represents mean nuclear/cytosol fluorescence intensity ratio in HEK293 cells transfected with GFP-NFAT only. (B and C) Asterisks indicate statistically significant of difference to TRPC3-WT–expressing cells. (D) Representative fluorescence images recorded in GFP-NFAT translocation experiments shown at Left. Positions of nuclei are indicatedby arrowheads. Nucleus/cytosol fluorescence ratios of example images are indicated.
10558 | www.pnas.org/cgi/doi/10.1073/pnas.1106183108 Poteser et al.
large-agonist–induced Ca2+ entry signals that were not accom-panied by significant NFAT nuclear accumulation (Fig. 5). This“transcriptionally silent”Ca2+ entry intoHL-1 cells was for a large
part mediated by voltage-gated L-type Ca2+ channels as indicatedby sensitivity to nifedipine (3 μM). Our results demonstrate dis-ruption of transcriptional TRPC3 signaling in response to reduced
A
B
C
D
Fig. 3. Ca2+ entry through TRPC3 is critical for activation of the calcineurin/NFAT pathway in HL-1 atrial myocytes. HL-1 cells were transfected with vectorcontrol (A), TRPC3-WT (B), or the indicated pore mutant (C and D). (Left) Representative traces of fura-2 imaging in cells at basal conditions (unstimulated +Ca2+ readdition) and stimulated with 100 nM endothelin (+ ET-1, arrow) in the absence or presence of 3 μM nifedipine (+ Nif). (Center Left) Mean fura-2 Δratio values (± SEM, n > 20). (Center Right) Mean nuclear/cytosolic NFAT-GFP fluorescence ratio (± SEM, n > 8) in unstimulated HL-1 cells (basal), HL-1 cellsstimulated with 100 nM endothelin (+ ET-1) in the absence and presence of 3 μM nifedipine (+ Nif) and application of the same protocol as used in fura-2experiments. Asterisks indicate statistically significant inhibition by nifedipine. (Right) Representative images of NFAT-localization before stimulation andCa2+ readdition (control), after Ca2+ readdition (basal), and after stimulation by endothelin and subsequent Ca2+ readdition (+ ET-1) in the absence andpresence of 3 μM nifedipine (+ Nif). Positions of nuclei are indicated by arrows. Nucleus/cytosol fluorescence ratios of example images are indicated.
Poteser et al. PNAS | June 28, 2011 | vol. 108 | no. 26 | 10559
CELL
BIOLO
GY
PKC-dependent phosphorylation of the channel or as a conse-quence of the TRPC3-Mwk mutation. This fact may be consid-ered as part of the molecular mechanism underlying the moon-walker pathophysiology (23).Impaired PKC regulation of cardiac TRPC3 is shown to result in
uncoupling from the NFAT pathway without disrupting the link-age between TRPC3 and global myocyte Ca2+ via voltage-gatedCa2+ entry. We provide evidence that TRPC3-CaN/NFATsignaling takesplace in a restrictedmicrodomain and requiresbothdirect Ca2+ permeation through the TRPC3 pore as well as CaNtargeting into the signal complex. Cardiac TRPC3 complexes areshown to produce Ca2+ signals both via direct Ca2+ transport andby control of voltage-dependent Ca2+ entry. Our results demon-strate the ability of cardiac TRPC3 channels to switch in a phos-phorylation-dependent manner between a transcriptionally activeand a transcriptionally silent signaling mode (Fig. 6). BecauseTRPC3 is likely to change in expression along with other TRPCspecies during pathophysiologic stress, the formation of divergent
heteromeric TRPC3 channel complexes may be anticipated. Theobserveddominantnegative effect of thephosphorylation-deficientmoonwalker mutation on CaN/NFAT activation suggests a prom-inent role of phosphorylation in maintenance of transcriptionallyactive TRPC complexes in the heart. Situations of hamperedPKC phopshorylation or promoted dephosphorylation may con-vert TRPC complexes into a cardiac Ca2+ signaling unit that isfunctionally isolated from the CaN/NFAT activation pathway.Our findings highlight the key role of nonselective TRPC
channels in the control of transcriptional programs and extendthis concept by demonstrating a pivotal role of Ca2+ transporttrough the TRP pore structure along with a unique phosphory-lation-dependent molecular switch that allows efficient control ofcardiac gene transcription by neurotransmitters and hormones.
Materials and MethodsHomology Modeling. For details on sequence alignment, homology modelingand model evaluation, see SI Materials and Methods.
A
B C
Fig. 4. GF109203X inhibits phosphorylation of TRPC3and its association with calcineurin. HEK-293 cellsexpressing HA-tagged TRPC3 were incubated with orwithout 2 μM GF109203X (GFX) and lysed and sub-jected to SDS/PAGE and immunoprecipitation. (A Left)Total HEK-cell lysates were immunoprecipitated byusing an anti-HA antibody and immunoblotted withan anti-phospho-threonine antibody. (A Right) Barsrepresenting the densitometric analysis of phospho-threonine-immunoreactivity. Mean values are givenfor carbachol-stimulated cells in the absence and pres-ence of GFX (± SEM, n = 4). Asterisk indicates statisti-cally significant differences. (B) Stripped membraneswere immunoblotted again by using an anti-HA anti-body (Lower). Proteins detected in total cell lysates(lane 1, Input), immunocomplexes (lane 2, IP-HA-C3)and lysates precipitated only with beads (lane 3, Ctrl.).(C) Coimmunoprecipitations of cell homogenates usingantibodies against the HA-tag and calcineurin, andimmunoblotted against calcineurin. Proteins detectedin total cell lysates (lane 1, Input), immunocomplexes(lane 2, IP-HA-C3; lane 3, IP-CN), and lysates pre-cipitated only with beads (lane 4, Ctrl.).
A B C D
Fig. 5. Phosphorylation of threonine 573 of the TRPC3 channel protein is essential for the activation of the calcineurin/NFAT pathway in HL-1 atrial myocytes. (A)Representative traces of fura-2 Ca2+-imaging experiments in cells transfected with either TRPC3-WT or TRPC3-T573A and TRPC3-WT (DNA ratio 3:1, MWK/TRPC3-WT), stimulated by 100nMendothelin (arrow) and in the absence or presence of 3 μMnifedipine (+Nif) or 2 μMGF109203X (+GFX), as indicated. (B)MeanΔ ratiovalues (± SEM, n > 30) of fura-2 Ca2+-imaging experiments. Asterisks indicate statistically significant nifedipine-induced inhibition. (C) Mean nucleus/cytosolfluorescence intensity ratio (± SEM, n> 9) in HL-1 cells expressingGFP-NFAT and the respective (mutant) channel protein after stimulation and application of thesame protocol as used in fura-2 experiments. (B and C) Asterisks indicate statistically significant difference to TRPC3-WT–expressing cells in the absence ofinhibitors (white bar). (D) Representative fluorescence images recorded in GFP-NFAT translocation experiments. Individual nucleus/cytosol fluorescence ratiosare given, and positions of nuclei are indicated by arrows.
10560 | www.pnas.org/cgi/doi/10.1073/pnas.1106183108 Poteser et al.
DNA and Mutagenesis. Site-directed mutagenesis was performed with stan-dard protocols. Details on cDNA constructs and cloning procedures areprovided in SI Materials and Methods.
Cell Culture and Transfection. Cell lines were cultured at 37 °C and 5%CO2. ForHEK293 cells DMEM (Invitrogen) supplied with 10% FCS and for HL-1 atrialmyocytes Claycomb medium (Sigma) supplied with 100 μM norepinephrin,4mM L-glutamin and 10%FCSwere used. Lipofectionwas used for gene trans-fer; for details on DNA amounts and reagents, see SI Materials and Methods.
Electrophysiology. Standard patch clamp protocols were used (SI Materialsand Methods). Standard bath solutions contained 140 or 0 mM NaCl, 0 or140 mM NMDG, 2 mM MgCl2, 10 mM glucose, 10 mM Hepes, 2 or 0 mMCaCl2, and 0 or 2 mM BaCl2 at pH adjusted to 7.4 with NaOH or NMDG. Pi-pette solution contained 120 mM cesium methanesulfonate, 20 mM CsCl,15 mM Hepes, 5 mM MgCl2, and 3 mM EGTA, at pH adjusted to pH 7.3 with
CsOH. For delineation of Ca2+ permeability of TRPC3 mutants, a bath solu-tion containing 132 mM NMDG, 2 mM MgCl2, 10 mM Glucose, 10 mM Hepes,3 mM CaCl2, 7 mM Ca-Gluconate, at pH adjusted to 7.4 with methanesulfonicacid and a pipette solution composed of 140 mM cesium methanesulfonate,15 mM Hepes, 5 mM MgCl2, and 10 mM BAPTA at pH 7.3 was used.
Measurement of NFAT-Translocation. Cells were transfected to express an N-terminally GFP-tagged NFATc1 fusion (15) and plated on coverslips. Forbuffers and solutions see SI Materials and Methods. Agonists as well asinhibitors (Pyr3, GFX109203, nifedipine, or KB-R7943) remained presentcontinuously after administration. GFP-NFAT translocation was monitored(488 nm excitation) with standard fluorescence microscopy (Zeiss Axiovertequipped with Coolsnap HQ). GFP-NFAT and YFP-TRPC3-WT/-mutant fluo-rescence were discriminated by specific cellular localization. Nuclear/cytosolfluorescence intensity ratios of cells were calculated with ImageJ software.
Measurement of Intracellular Ca2+ Signaling. For details on fura-2 calciumimaging experiments see SI Materials and Methods.
Immunoprecipation. In short, protein-A- or protein-G-bead-preclearedsupernatants of lysates from stimulated HEK293 cells were incubated withprecipitating antibody overnight. After the addition of respective protein-A-or protein-G-beads, washing, and denaturation in Lämmli buffer, the im-munocomplexes were separated by SDS/PAGE and subjected to Westernblotting. See SI Materials and Methods for details.
Reagents. Chemicals, reagents, and antibodies were purchased from SigmaAldrich. KB-R7943 and GF109203X were from Tocris Biosciences. The TRPC3pore blocker Pyr3 was synthesized as published (16).
Statistics. Data are presented as mean values ± SEM and was tested forstatistical significance by using the Student t test (*P < 0.05).
ACKNOWLEDGMENTS. We thank Dr. R. Kehlenbach for providing the GFP-NFAT construct and Mrs. R. Schmidt for excellent technical assistance. Thiswork was supported by FWF (Austrian Science Fund) Grant P21925-B19(to K.G.), P22565 (to C.R.), and DK+Metabolic and Cardovascular DiseaseGrant W2126-B18.
1. Kranias EG, BersDM(2007) Calciumandcardiomyopathies. Subcell Biochem45:523–537.2. Bush EW, et al. (2006) Canonical transient receptor potential channels promote
cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem
281:33487–33496.3. Kuwahara K, et al. (2006) TRPC6 fulfills a calcineurin signaling circuit during
myopathy is activated by TRPC in the adult mouse heart. FASEB J 20:1660–1670.5. Montell C, Birnbaumer L, Flockerzi V (2002) The TRP channels, a remarkably
functional family. Cell 108:595–598.6. Owsianik G, Talavera K, Voets T, Nilius B (2006) Permeation and selectivity of TRP
channels. Annu Rev Physiol 68:685–717.7. Onohara N, et al. (2006) TRPC3 and TRPC6 are essential for angiotensin II-induced
cardiac hypertrophy. EMBO J 25:5305–5316.8. Rosker C, et al. (2004) Ca(2+) signaling by TRPC3 involves Na(+) entry and local
coupling to the Na(+)/Ca(2+) exchanger. J Biol Chem 279:13696–13704.9. Eder P, Groschner K (2008) TRPC3/6/7: Topical aspects of biophysics and
pathophysiology. Channels (Austin) 2:94–99.10. Kamouchi M, et al. (1999) Properties of heterologously expressed hTRP3 channels in
bovine pulmonary artery endothelial cells. J Physiol 518:345–358.11. Eder P, et al. (2007) Phospholipase C-dependent control of cardiac calcium
homeostasis involves a TRPC3-NCX1 signaling complex. Cardiovasc Res 73:111–119.12. Molkentin JD (2006) Dichotomy of Ca2+ in the heart: Contraction versus intracellular
signaling. J Clin Invest 116:623–626.
13. Notredame C, Higgins DG, Heringa J (2000) T-Coffee: A novel method for fast andaccurate multiple sequence alignment. J Mol Biol 302:205–217.
14. Liu CH, et al. (2007) In vivo identification and manipulation of the Ca2+ selectivityfilter in the Drosophila transient receptor potential channel. J Neurosci 27:604–615.
15. Nilius B, et al. (2005) The selectivity filter of the cation channel TRPM4. J Biol Chem280:22899–22906.
16. Voets T, Janssens A, Droogmans G, Nilius B (2004) Outer pore architecture of aCa2+-selective TRP channel. J Biol Chem 279:15223–15230.
17. Garcia-Martinez C, Morenilla-Palao C, Planells-Cases R, Merino JM, Ferrer-Montiel A(2000) Identification of an aspartic residue in the P-loop of the vanilloid receptor thatmodulates pore properties. J Biol Chem 275:32552–32558.
18. Seth M, et al. (2009) TRPC1 channels are critical for hypertrophic signaling in theheart. Circ Res 105:1023–1030.
19. Kiyonaka S, et al. (2009) Selective and direct inhibition of TRPC3 channels underliesbiological activities of a pyrazole compound. Proc Natl Acad Sci USA 106:5400–5405.
20. Sinkins WG, Goel M, Estacion M, Schilling WP (2004) Association of immunophilinswith mammalian TRPC channels. J Biol Chem 279:34521–34529.
21. Kim JY, Saffen D (2005) Activation of M1 muscarinic acetylcholine receptorsstimulates the formation of a multiprotein complex centered on TRPC6 channels.J Biol Chem 280:32035–32047.
22. Trebak M, et al. (2005) Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712. Mol Pharmacol 67:558–563.
23. Becker EB, et al. (2009) A point mutation in TRPC3 causes abnormal Purkinje celldevelopment and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci USA 106:6706–6711.
Fig. 6. Phosporylation of TRPC3 at position 573 (via PLC) enables Ca2+/calmodulin/calcineurin (Ca2+, Cm, CaN)-dependent activation upon receptor-activated Ca2+ entry through TRPC3. Dephosporylation of position 573 turnsTRPCtranscriptionally silentwhileenhancing its general activity. L-type channelsare controlled by TRPC3-induced changes in membrane potential, providingonly negligible effects on Ca2+-induced NFAT activation in HL-1 atrial myocytes.
Poteser et al. PNAS | June 28, 2011 | vol. 108 | no. 26 | 10561
CELL BIOLOGYCorrection for “PKC-dependent coupling of calcium permeationthrough transient receptor potential canonical 3 (TRPC3) tocalcineurin signaling in HL-1 myocytes,” by Michael Poteser,Hannes Schleifer, Michaela Lichtenegger, Michaela Schern-thaner, Thomas Stockner, C. Oliver Kappe, Toma N. Glasnov,Christoph Romanin, and Klaus Groschner, which appeared in
issue 26, June 28, 2011, of Proc Natl Acad Sci USA (108:10556–10561; first published June 8, 2011; 10.1073/pnas.1106183108).The authors note that Figs. 2, 3, and 5 appeared incorrectly.
The corrected figures and their corresponding legends appearbelow.
A B C D
Fig. 2. Receptor-stimulated Ca2+ influx as well as NFAT translocation are impaired in HEK293 cells expressing the Ca2+ impermeable TRPC3-E630Q or theimpermeant TRPC3-E630K, compared with cells expressing wild-type TRPC3. (A) Representative traces of fura-2 Ca2+-imaging experiments. Cells were stimu-lated by 100 μM carbachol (arrow). (B) Mean Δ ratio values (±SEM, n > 40) derived from fura-2 Ca2+-imaging. Black bars indicate the basal (unstimulated) Ca2+
entry at indicated transfections. (C) Mean nuclear/cytosol fluorescence intensity ratio (±SEM, n > 11) of HEK293 cells expressing GFP-NFAT and the respectivechannel protein after stimulation and application of the same protocol as used in fura-2 experiments. Black bar (basal) represents mean nuclear/cytosolfluorescence intensity ratio in HEK293 cells transfected with GFP-NFAT only. (B and C) Asterisks indicate statistically significance of difference to TRPC3-WT–expressing cells. (D) Representative fluorescence images recorded in GFP-NFAT translocation experiments shown at Left. Positions of nuclei are indicated byarrowheads. Nucleus/cytosol fluorescence ratios of example images are indicated.
Fig. 3. Ca2+ entry through TRPC3 is critical for activation of the calcineurin/NFAT pathway in HL-1 atrial myocytes. HL-1 cells were transfected with vectorcontrol (A), TRPC3-WT (B), or the indicated pore mutant (C and D). (Left) Representative traces of fura-2 imaging in cells at basal conditions (unstimulated +Ca2+ readdition) and stimulated with 100 nM endothelin (+ ET-1, arrow) in the absence or presence of 3 μM nifedipine (+ Nif). (Center Left) Mean fura-2 Δratio values (±SEM, n > 20). (Center Right) Mean nuclear/cytosolic NFAT-GFP fluorescence ratio (±SEM, n > 8) in unstimulated HL-1 cells (basal), HL-1 cellsstimulated with 100 nM endothelin (+ ET-1) in the absence and presence of 3 μM nifedipine (+ Nif) and application of the same protocol as used in fura-2experiments. Asterisks indicate statistically significant inhibition by nifedipine. (Right) Representative images of NFAT-localization before stimulation and Ca2+
readdition (control), after Ca2+ readdition (basal), and after stimulation by endothelin and subsequent Ca2+ readdition (+ ET-1) in the absence and presence of3 μM nifedipine (+ Nif). Positions of nuclei are indicated by arrowheads. Nucleus/cytosol fluorescence ratios of example images are indicated.
Fig. 5. Phosphorylation of threonine 573 of the TRPC3 channel protein is essential for the activation of the calcineurin/NFAT pathway in HL-1 atrial myocytes.(A) Representative traces of fura-2 Ca2+-imaging experiments in cells transfected with either TRPC3-WT or TRPC3-T573A and TRPC3-WT (DNA ratio 3:1, MWK/TRPC3-WT), stimulated by 100 nM endothelin (arrow) and in the absence or presence of 3 μM nifedipine (+ Nif) or 2 μM GF109203X (+ GFX), as indicated. (B)Mean Δ ratio values (±SEM, n > 30) of fura-2 Ca2+-imaging experiments. Asterisks indicate statistically significant nifedipine-induced inhibition. (C) Meannucleus/cytosol fluorescence intensity ratio (±SEM, n > 9) in HL-1 cells expressing GFP-NFAT and the respective (mutant) channel protein after stimulation andapplication of the same protocol as used in fura-2 experiments. (B and C) Asterisks indicate statistically significant difference to TRPC3-WT–expressing cells inthe absence of inhibitors (white bar). (D) Representative fluorescence images recorded in GFP-NFAT translocation experiments. Individual nucleus/cytosolfluorescence ratios are given, and positions of nuclei are indicated by arrowheads.
Supporting InformationPoteser et al. 10.1073/pnas.1106183108SI Materials and MethodsSequence Alignment. Sequence alignments between TRPC3 andthe template protein were carried out by applying a hierarchicalapproach using the alignment programs T-Coffee, M-Coffee (1),and Muscle (2). Sequencing of TRPC, KcsA, and Kv1.2 channelswere collected with Blast (3, 4) by using the query sequences ofhuman TRPC3 (UniProtKB ID: Q13507), KcsA (UniProtKBID: P0A334), and the sequence of the Kv1.2–2.1 chimera asdeposited in the Protein Data Bank database (PDB ID code:2R9R). Initial alignments for each subset were performed withMuscle by using gapopen = −3. Only the pore-forming regions(TM5 to TM6) were retained. The ≈30 most diverse sequenceswere extracted from the alignment by using T-Coffee. In thesecond step, the three (TRPC, KcsA, and Kv1.2) alignmentswere merged by a consensus alignment using M-Coffee applyingt-coffee probcons (5), muscle, kalign (6), and clustalW (7) scores.The merged alignment was realigned with Muscle, the numberof sequences was again reduced to 40 sequences, and a finalalignment was created by using T-Coffee applying the blosum40matrix (8), using a gapopen penalty of 300, and applying t-coffeeprobcons, muscle and kalign scores. Variation of parameters andprocedure resulted in three possible alignments.
Alignment Evaluation.Alignment evaluation was carried out at thesequence level and at the 3D structural level. At the sequence level,clustalW scores, secondary structure prediction, alignment of ar-omatic residues in the pore helix, and hydrophobic-hydrophilicpatter were used. The secondary structure prediction was carriedout by using Jpred3 (9, 10). The predictions were compared withthe 3D model created and evaluated for compatibility.3D homology models were built as described below. Com-
patibility of resulting models with protein structure stability(charged groups should be water exposed, helix-helix packing andposition of helix breaking residues) and similarity of hydrophobic,polar and charged residues between the model and the templatewere evaluated. One alignment showed much higher likeliness ofbeing correct.
Homology Model. The homology model of the TRPC3 poreforming region (TM5 to TM6) was generated by using the Kv1.2–2.1 structure with the PDB ID code 2R9R as a template andapplying the final sequence alignment. Model creation was donewith the program modeler (11, 12) applying the multichainprotocol that allows for maintaining the same conformation inevery protomer of the TRPC3 tetramer.
DNAandMutagenesis.TheQuikChangeIISit-DirectedMutagenesisKit (Stratagene) was used formutagenesis. Template was a plasmidconstruct with wild-type human TRPC3 cloned into pEYFP-C1,creating an N-terminally YFP-tagged fusion protein. The plasmidswere electrotransformed into the XL-1 e.coli strain for amplificationand correct nucleotide exchange was verified by sequencing.For some experiments, an untagged TRPC3-WT cloned into
the pcDNA3 vector was coexpressed with the mutants. For ob-servation of NFAT nuclear translocation and for immunopreci-pitations, an N-terminally HA-tagged TRPC3 construct was used.The empty peYFP-C1 vector served as control.
Electrophysiology. Patch pipettes were pulled from borosilicateglass (Clark Electromedical Instruments; 3–5 MΩ). Currentswere recorded at room temperature by using a List EPC7 patchclamp amplifier (HEKA Instruments). Signals were low-pass
filtered at 1 kHz and digitized with 5 kHz. Voltage-clamp pro-tocols (voltage ramps from –100 to +80 mV, holding potential0 mV) were controlled by pClamp software (Axon Instruments).
NFAT-Translocation. Measurements were performed at roomtemperature and started in a Ca2+-free buffer containing 140 mMNaCl, 2 mM MgCl2, 10 mM Glucose, and 10 mM Hepes at pH7.4. After 5 min, incubation cells were challenged with 100 μMcarbachol (HEK293) or 100 nM endothelin (HL-1) and 2 mMCa2+
was readded in a low sodium buffer: 100 mM NaCl, 40 mMNMDG, 2 mM Ca2+, 3 mM MgCl2, 10 mM glucose, and 10 mMHepes at pH 7.4 and incubated for 15 min.
Measurement of Intracellular Ca2+ Signaling. Cells were loaded with2 μM fura 2-AM (Molecular Probes) for 45 min in Optimem me-dium (Invitrogen) and washed. Cells were continuously perfused atroom temperature with calcium-free buffer and challenged withcarbachol (HEK293) or endothelin (HL-1). Agonists as well asinhibitors remained present continuously after administration.For calcium readdition, 2 mM extracellular CaCl2 was added. Ex-citation light was supplied via a Polychrome II polychromator(TILL Photonics) and emission was detected by a Sensicam CCD-camera (PCOComputer Optics). Ca2+-sensitive fluorescence ratios(340 nm/380 nm excitation; 510 nm emission) were recorded andanalyzed by using Axon Imaging Workbench (Axon Instruments).
Cell Culture and Transfection. For transfection, HEK293 cells or HL-1atrial myocytes were seeded at 105 cells per well into 30-mm dishes.After ≈18 h, adherent cells were transfected either using Transfast(Promega; for HEK293) or FuGENE (Roche; for HL-1) trans-fection reagent according to the manufacturer’s instructions. DNA(4–5 μg) was used for single transfections (YFP-TRPC3-WT/-mu-tant, YFP-vector) per dish. For the measurement of NFAT-trans-location, double transfection of 2 μg of GFP-NFAT+ 2 μg of YFP-TRPC3-WT/-mutant or triple transfection of 1 μg of GFP-NFATand 4 μg of YFP-TRPC3-T573A (Mwk) + untagged TRPC3-WT(in 3:1) was used. Approximately 18 h after the transfection, cellswere trypsinized and reseeded 1:2 on polylysine (for HEK293) orfibronectin (for HL-1) coated on 12 mm or 6 × 6 mm coverslips andincubated for 18 h before experiments.
Immunoprecipation. HEK293 cells were grown in 100-mm Petridishes and, if required, transfected. Eighteen to twenty-four hoursafter transfection or for wild-type cells at confluency, cells wereincubated as for the NFAT translocation experiments. At the end,cells were scraped off the dishes, resuspended in 5 mL of PBS, andcentrifuged for 5 min [188 × g, Sorvall (Asheville, NC), RT 7,RTH-250, 4 °C]. The pellet was lysed with 500 μL of MammalianCell Lysis Buffer (QIAGEN), containing 5 μL of protease in-hibitor solution. The lysate was shaken overhead for 30 min at4 °C and centrifuged with high speed for 5 min. Proteins from celllysates (500 mg) were incubated with 50 μL of washed protein-Aor protein-G beads (Merck) and PBS for a final volume of 500 μLand gently rotated for 40–50 min at 4 °C to remove nonspecificbound proteins. Precleared supernatants were incubated over-night at 4 °C under rotation with 3 μg of antibody against HA andcalcineurin, respectively. On the following day, 60 μL of washedprotein-A or protein-G beads were added and gently rotated for2 h at room temperature. The beads were washed three timeswith ice-cold PBS containing 1% Triton and heated to 95 °C afterresuspension in 50 μL of 2× Lämmli buffer. The immuno-complexes were separated by SDS/PAGE and transferred to ni-trocellulose membranes (Hybond ECL nitrocellulose, Amersham
Poteser et al. www.pnas.org/cgi/content/short/1106183108 1 of 7
Biosciences), followed by blocking for 1 h at RT with 5% nonfatdry milk in PBST (0.1% Tween in PBS) and TBST (0.2% Tween20 in TBS), respectively. Nitrocellulose membranes were incubatedovernight at 4 °C with antibodies against HA (1:800 in TBST;Roche), phospho-threonine (1:1,000 in TBST, Cell Signaling orcalcineurin (1:2,000 in TBST; BD Transduction Laboratories).After four washes (10 min each), the secondary antibodies, anti-rabbit IgG (Sigma Aldrich), anti-mouse IgM (Sigma Aldrich) or
anti-mouse IgG (BD Transduction Laboratories) cross-linkedwith horseradish peroxidase (1:5,000) were applied for 1 h atroom temperature and the washing was repeated. Membraneswere detected by the Chemi Glow West ChemiluminescenceSubstrate Sample Kit (Alpha Innotech) and developed by usinga Herolab RH-5.2 Darkroom Hood with an E.A.S.Y 1.3 HCcamera (Herolab).
1. Wallace I-M, et al. (2006) M-Coffee: Combining multiple sequence alignment methodswith T-Coffee. Nucleic Acids Res 34:1692–1699.
2. Edgar R-C (2004) MUSCLE: Multiple sequence alignment with high accuracy and highthroughput. Nucleic Acids Res 32:1792–1797.
3. Altschul S-F, Gish W, Miller W, Myers E-W, Lipman D-J (1990) Basic local alignmentsearch tool. J Mol Biol 215:403–410.
4. Altschul S-F, et al. (1997) Gapped BLAST and PSI-BLAST: A new generation of proteindatabase search programs. Nucleic Acids Res 25:3389–3402.
5. Do C-B, Mahabhashyam M-S-P, Brudno M (2005) ProbCons: Probabilistic consistency-based multiple sequence alignment. Genome Res 15:330–340.
6. Lassmann T, Sonnhammer E-L-L (2005) Kalign - an accurate and fast multiple sequencealignment algorithm. BMC Bioinformatics 6:298.
7. Chenna R, Sugawara H, Koike T (2003) Multiple sequence alignment with the Clustalseries of programs. Nucleic Acids Res 31:3497–3500.
8. Henikoff S, Henikoff J-G (1993) Performance evaluation of amino-acid substitutionmatrices. Protein-Structure Function and Genetics 17:49–61.
9. Cuff J-A, Clamp M-E, Siddiqui A-S, Finlay M, Barton G-J (1998) Jpred: A ConsensusSecondary Structure Prediction Server. Bioinformatics 14:892–893.
10. Cole C, Barber J-D, Barton G-J (2008) The Jpred 3 secondary structure predictionserver. Nucleic Acids Res. 36(Web Server issue):W197–W201.
11. Marti-RenomM-A, et al. (2000) Comparative protein structure modeling of genes andgenomes. Annu Rev Biophys Biomol Struct 29:291–325.
12. Sali A, Blundell T-L (1993) Comparative protein modelling by satisfaction of spatialrestraints. J Mol Biol 234:779–815.
Fig. S1. Computational homology model of the TRPC3 pore region, based on the structure of KcsA and Kv1.2. (A) Side view on TRPC3 TM5 + TM6 of twoopposite subunits (Left) and view from the extracellular side (Right) showing the pore structure of the homotetrameric channel. Charged glutamate residuesare marked in red, green, and yellow. (B) Sequence alignment of the putative pore region of KcsA and TRPC3. Glutamate and aspartate residues of the TRPC3pore region and the corresponding amino acid residues of KcsA are indicated as well as the calculated accessibility prediction (B = buried) and the accessibilityprediction probability value (0–9) for the corresponding residue. Charged amino acids E616, E630, and D639 appear accessible for ion binding.
Poteser et al. www.pnas.org/cgi/content/short/1106183108 2 of 7
Fig. S3. Currents through TRPC3-E630Q do not display changes in reversal potential upon reduction in extracellular Ca2+. (A) Current recordings of un-stimulated (control, 1) or stimulated (+ CCh, 100 μM) TRPC3-E630Q expressing HEK293 cells in Na+/Ca2+ solution (2) and Na+ only (3). (B) Mean reversal potential(± SEM, n > 6) of carbachol-induced currents in TRPC3-E630Q expressing HEK293 cells in Na+/Ca2+ solution and Na+ only.
Fig. S2. Stimulation by carbachol does not induce currents in TRPC3-E630K transfected HEK293 cells. (A) Representative current recordings of HEK293 cellstransfected with TRPC3-E630K (E630K) unstimulated (basal, black) and stimulated with 100 μM carbachol (red). (B) Mean current densities (± SEM, n > 6) ofHEK293 cells transfected with TRPC3-WT unstimulated (basal), HEK293 cells transfected with either TRPC3-WT or E630K and stimulated with 100 μM carbachol(+ CCh). Asterisk indicates statistical significant difference to stimulated TRPC3-WT expressing cells.
Poteser et al. www.pnas.org/cgi/content/short/1106183108 3 of 7
Fig. S4. Receptor stimulated Ca2+ entry into TRPC3-WT transfected HEK293 cells (A) is insensitive to 3 μM nifedipine (Nif, arrow) but inhibited by 3 μM Pyr3and moderately reduced by acute administration (arrow) of 5 μM KB-R7943 (KBR), whereas receptor-stimulated Ca2+ entry in atrial myocytes (HL-1; B) is highlysensitive to inhibtion 3 μM nifedipine (Nif, arrow) as well as 3 μM Pyr3, but not to acute administration of 5 μM KBR (arrow). (Left) Representative traces offura-2 Ca2+-imaging experiments. Arrows indicate the time points of addition of either 100 nM endothelin or the inhibitory drugs. (Right) Inhibition (in percent ±SEM, n > 30) of readdition-induced Ca2+ plateau by 3 μM Pyr3, 3 μM Nif, or 5 μM KBR. Arrowheads denote values close to zero.
Poteser et al. www.pnas.org/cgi/content/short/1106183108 4 of 7
Fig. S5. TRPC3 channels are still active at the time of Ca2+ readdition in fura-2 imaging experiments. (A) Representative time course of currents at 70 mVand −70 mV in TRPC3-WT expressing HEK293 cells stimulated with 100 μM carbachol in the absence of extracellular Ca2+. (B) Mean current densities (70 mV,−70 mV, ± SEM) of TRPC3wt expressing HEK293 cells, recorded during before stimulation (1) and 100 s after stimulation with carbachol (time point of Ca2+
entry initiation in fura-2 imaging experiments; 2).
Fig. S6. The pyrazole compound Pyr3, but not KB-R7943, inhibits NFAT translocation in TRPC3-WT expressing HEK293 cells. (Left) Mean nuclear/cytosolfluorescence intensity ratio (± SEM, n > 11) of HEK293 cells expressing GFP-NFAT and TRPC3-WT before (basal) and after stimulation with 100 μM carbachol(CCh) and application of the same protocol as used in fura-2 experiments in the absence or presence of 5 μM KB-R7943 (KBR) or 3 μM Pyr3. Asterisks indicatestatistically significant difference to basal conditions. (Right) Representative images of NFAT translocation at basal conditions (basal), after stimulation with100 μM carbachol (+CCh), and after stimulation by carbachol after incubation by 5 μM KB-R7943 (KBR) or 3 μM Pyr3. Individual nuclear/cytosol fluorescenceratios are indicated. Positions of nuclei are indicated by arrowheads.
Poteser et al. www.pnas.org/cgi/content/short/1106183108 5 of 7
Fig. S7. Thapsigargin promotes NFAT translocation in TRPC3-WT expressing HEK293 cells, but not in HL-1 cells. (A) Mean nuclear/cytosolic NFAT-GFP fluorescenceratio (± SEM, n > 11) in unstimulated cells (basal), in cells challenged by 100 μM carbachol (CCh) or 1 μM thapsigargin (TG). (A Right) Representative images ofNFAT localization before Ca2+ readdition (control), after Ca2+ readdition (basal), after stimulation by 100 μM CCh or 1 μM TG and subsequent Ca2+ readdition.Nuclear/cytosol fluorescence ratios and positions of nuclei (arrowheads) are indicated. (B) Mean nuclear/cytosolic NFAT-GFP fluorescence intensity ratio (± SEM, n >8), in unstimulated HL-1 cells (basal), HL-1 cells challenged by 1 μM TG, and TG stimulated in the presence of 3 μM nifedipine (Nif). (B Right) Representative imagesof NFAT translocation before stimulation and Ca2+ readdition (control), after Ca2+ readdition (basal), after stimulation by 1 μM TG and subsequent Ca2+ readdition(+ TG) as well as after stimulation and Ca2+ readdition in the presence of 3 μMnifedipine (+ TG + Nif). Individual nuclear/cytosol fluorescence ratios and positions ofnuclei are indicated (arrows). Standard Ca2+ readdition protocols were used. Asterisks indicate statistical significance vs. basal.
Poteser et al. www.pnas.org/cgi/content/short/1106183108 6 of 7
Fig. S8. Heteromeric channels consisting of the mutant TRPC3-T573A (MWK) and TRRPC3-WT (MWK:WT = 3:1) show enhanced current densities and per-sistent activity upon stimulation in HEK293 cells. (A) Representative time-course of currents at 70 mV and −70 mV recorded from HEK293 cells expressingTRPC3-T573A (MWK, circles) or TRRPC3-WT (squares) and stimulated with 100 μM carbachol (arrow). (B) Mean current densities (± SEM, n > 8) of TRPC3-WT andTRPC3-T573A (MWK) expressing HEK293 cells at basal, unstimulated conditions (B) and peak current after stimulation with 100 μM carbachol (P). (B Right)Representative images of HEK293 cells expressing TRPC3-WT or TRPC3-T573A (MWK)/TRPC3-WT (3:1). (C) Current recordings of unstimulated (black) andstimulated (red, carbachol 100 μM) TRPC3-T573A/TRPC3-WT (3:1, MWK; Left) and TRPC3-E630Q (E630Q; Right) expressing HEK293 cells in Na+-free, Ca2+
containing solution (2 mM).
Poteser et al. www.pnas.org/cgi/content/short/1106183108 7 of 7
Novel pyrazole compounds for pharmacological discrimination
between receptor-operated and store-operated Ca2+ entry pathways.
Br J Pharmacol (2012) - submitted 31.01.2012
H Schleifer1, B Doleschal2, M Lichtenegger2, R Oppenrieder2, I Derler3, I Frischauf3, T N
Glasnov4, C O Kappe4, C Romanin3 and K Groschner1,2
1
Institute of Biophysics, Medical University of Graz, 8010 Graz, Austria
2 Institute of Pharmaceutical Sciences, Department of Pharmacology and Toxicology, University of Graz, 8010
Graz, Austria
3 Institute for Biophysics, University of Linz, 4040 Linz, Austria and
4 Christian Doppler Laboratory for Microwave Chemistry, Institute of Chemistry, University of Graz, 8010 Graz,
Austria
For Peer Review
Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-
operated Ca2+ entry pathways
Journal: British Journal of Pharmacology
Manuscript ID: 2012-BJP-0113-RP
Manuscript Type: Research Paper
Date Submitted by the Author:
31-Jan-2012
Complete List of Authors: Schleifer, Hannes; Medical University of Graz, Institute of Biophysics
Doleschal, Bernhard; University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacology and Toxicology Lichtenegger, Michaela; University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacology and Toxicology Oppenrieder, Regina; University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacology and Toxicology Derler, Isabella; University of Linz, Institute of Biophysics Frischauf, Irene; University of Linz, Institute of Biophysics Glasnov, Toma; University of Graz, Christian Doppler Laboratory for Microwave Chemistry, Institute of Chemistry
Kappe, Christian; University of Graz, Christian Doppler Laboratory for Microwave Chemistry, Institute of Chemistry Romanin, Christoph; University of Linz, Institute of Biophysics Groschner, Klaus; Medical University of Graz, Institute of Biophysics; University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacology and Toxicology
Abramowitz J, Birnbaumer L (2009). Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 23(2): 297-328. Abramowitz J, Yildirim E, Birnbaumer L (2007). The TRPC Family of Ion Channels: Relation to the TRP Superfamily and Role in Receptor- and Store-Operated Calcium Entry TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. edn. Taylor & Francis Group, LLC: Boca Raton FL. Ambudkar IS (2007). TRPC1: a core component of store-operated calcium channels. Biochem Soc Trans 35(Pt 1): 96-100. Anderluh G, Barlic A, Podlesek Z, Macek P, Pungercar J, Gubensek F, et al. (1999). Cysteine-scanning mutagenesis of an eukaryotic pore-forming toxin from sea anemone: topology in lipid membranes. Eur J Biochem 263(1): 128-136. Baba Y, Hayashi K, Fujii Y, Mizushima A, Watarai H, Wakamori M, et al. (2006). Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum. Proc Natl Acad Sci U S A 103(45): 16704-16709. Bandyopadhyay BC, Ong HL, Lockwich TP, Liu X, Paria BC, Singh BB, et al. (2008). TRPC3 controls agonist-stimulated intracellular Ca2+ release by mediating the interaction between inositol 1,4,5-trisphosphate receptor and RACK1. J Biol Chem 283(47): 32821-32830. Becker EB, Fogel BL, Rajakulendran S, Dulneva A, Hanna MG, Perlman SL, et al. (2011). Candidate screening of the TRPC3 gene in cerebellar ataxia. Cerebellum 10(2): 296-299. Becker EB, Oliver PL, Glitsch MD, Banks GT, Achilli F, Hardy A, et al. (2009). A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci U S A 106(16): 6706-6711. Berridge MJ, Lipp P, Bootman MD (2000). The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1(1): 11-21. Birnbaumer L (2009). The TRPC class of ion channels: a critical review of their roles in slow, sustained increases in intracellular Ca(2+) concentrations. Annu Rev Pharmacol Toxicol 49: 395-426. Boulay G, Zhu X, Peyton M, Jiang M, Hurst R, Stefani E, et al. (1997). Cloning and expression of a novel mammalian homolog of Drosophila transient receptor potential (Trp) involved in calcium entry secondary to activation of receptors coupled by the Gq class of G protein. J Biol Chem 272(47): 29672-29680. Brandman O, Liou J, Park WS, Meyer T (2007). STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 131(7): 1327-1339. Branstrom R, Leibiger IB, Leibiger B, Klement G, Nilsson J, Arhem P, et al. (2007). Single residue (K332A) substitution in Kir6.2 abolishes the stimulatory effect of long-chain acyl-CoA esters: indications for a long-chain acyl-CoA ester binding motif. Diabetologia 50(8): 1670-1677. Brenner JS, Dolmetsch RE (2007). TrpC3 regulates hypertrophy-associated gene expression without affecting myocyte beating or cell size. PLoS One 2(8): e802. Bush EW, Hood DB, Papst PJ, Chapo JA, Minobe W, Bristow MR, et al. (2006). Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem 281(44): 33487-33496. Calloway N, Vig M, Kinet JP, Holowka D, Baird B (2009). Molecular clustering of STIM1 with Orai1/CRACM1 at the plasma membrane depends dynamically on depletion of Ca2+ stores and on electrostatic interactions. Mol Biol Cell 20(1): 389-399. Chapman ML, Krovetz HS, VanDongen AM (2001). GYGD pore motifs in neighbouring potassium channel subunits interact to determine ion selectivity. J Physiol 530(Pt 1): 21-33.
102
Chen S, Hartmann HA, Kirsch GE (1997). Cysteine mapping in the ion selectivity and toxin binding region of the cardiac Na+ channel pore. J Membr Biol 155(1): 11-25. Cheng KT, Liu X, Ong HL, Ambudkar IS (2008). Functional requirement for Orai1 in store-operated TRPC1-STIM1 channels. J Biol Chem 283(19): 12935-12940. Cheng KT, Liu X, Ong HL, Swaim W, Ambudkar IS (2011). Local Ca(2)+ entry via Orai1 regulates plasma membrane recruitment of TRPC1 and controls cytosolic Ca(2)+ signals required for specific cell functions. PLoS Biol 9(3): e1001025. Clapham DE (2003). TRP channels as cellular sensors. Nature 426(6966): 517-524. Cole C, Barber JD, Barton GJ (2008). The Jpred 3 secondary structure prediction server. Nucleic Acids Res 36(Web Server issue): W197-201. Corey DP (2003). New TRP channels in hearing and mechanosensation. Neuron 39(4): 585-588. Corey DP, Garcia-Anoveros J, Holt JR, Kwan KY, Lin SY, Vollrath MA, et al. (2004). TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature 432(7018): 723-730. Cosens DJ, Manning A (1969). Abnormal electroretinogram from a Drosophila mutant. Nature 224(5216): 285-287. DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW, Jr. (2008). Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 283(28): 19265-19273. Denis V, Cyert MS (2002). Internal Ca(2+) release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue. J Cell Biol 156(1): 29-34. Derler I, Fahrner M, Carugo O, Muik M, Bergsmann J, Schindl R, et al. (2009). Increased hydrophobicity at the N terminus/membrane interface impairs gating of the severe combined immunodeficiency-related ORAI1 mutant. J Biol Chem 284(23): 15903-15915. Dietrich A, Mederos YSM, Gollasch M, Gross V, Storch U, Dubrovska G, et al. (2005). Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol Cell Biol 25(16): 6980-6989. Djuric SW, BaMaung NY, Basha A, Liu H, Luly JR, Madar DJ, et al. (2000). 3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator. J Med Chem 43(16): 2975-2981. Eder P, Molkentin JD (2011). TRPC channels as effectors of cardiac hypertrophy. Circ Res 108(2): 265-272. Eder P, Poteser M, Groschner K (2007a). TRPC3: a multifunctional, pore-forming signalling molecule. Handb Exp Pharmacol(179): 77-92. Eder P, Probst D, Rosker C, Poteser M, Wolinski H, Kohlwein SD, et al. (2007b). Phospholipase C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1 signaling complex. Cardiovasc Res 73(1): 111-119. Fahrner M, Muik M, Derler I, Schindl R, Fritsch R, Frischauf I, et al. (2009). Mechanistic view on domains mediating STIM1-Orai coupling. Immunol Rev 231(1): 99-112. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, et al. (2006). A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441(7090): 179-185. Feske S, Prakriya M, Rao A, Lewis RS (2005). A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients. J Exp Med 202(5): 651-662. Freichel M, Vennekens R, Olausson J, Hoffmann M, Muller C, Stolz S, et al. (2004). Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. Biochem Biophys Res Commun 322(4): 1352-1358. Freichel M, Vennekens R, Olausson J, Stolz S, Philipp SE, Weissgerber P, et al. (2005). Functional role of TRPC proteins in native systems: implications from knockout and knock-down studies. J Physiol 567(Pt 1): 59-66.
103
Garcia RL, Schilling WP (1997). Differential expression of mammalian TRP homologues across tissues and cell lines. Biochem Biophys Res Commun 239(1): 279-283. Gaudet R (2007). Structural Insights into the Function of TRP Channels TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. edn. Taylor & Francis Group, LLC: Boca Raton FL. Gaudet R (2008). TRP channels entering the structural era. J Physiol 586(Pt 15): 3565-3575. Gibon J, Tu P, Bouron A (2010). Store-depletion and hyperforin activate distinct types of Ca(2+)-conducting channels in cortical neurons. Cell Calcium 47(6): 538-543. Glasnov TN, Groschner K, Kappe CO (2009). High-speed microwave-assisted synthesis of the trifluoromethylpyrazol-derived canonical transient receptor potential (TRPC) channel inhibitor Pyr3. ChemMedChem 4(11): 1816-1818. Graziani A, Poteser M, Heupel WM, Schleifer H, Krenn M, Drenckhahn D, et al. (2010). Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-beta-catenin interaction. J Biol Chem 285(6): 4213-4223. Greka A, Navarro B, Oancea E, Duggan A, Clapham DE (2003). TRPC5 is a regulator of hippocampal neurite length and growth cone morphology. Nat Neurosci 6(8): 837-845. Gwack Y, Srikanth S, Feske S, Cruz-Guilloty F, Oh-hora M, Neems DS, et al. (2007). Biochemical and functional characterization of Orai proteins. J Biol Chem 282(22): 16232-16243. Hardie RC (2007). TRP channels and lipids: from Drosophila to mammalian physiology. J Physiol 578(Pt 1): 9-24. Hardie RC, Minke B (1993). Novel Ca2+ channels underlying transduction in Drosophila photoreceptors: implications for phosphoinositide-mediated Ca2+ mobilization. Trends Neurosci 16(9): 371-376. Hardie RC, Minke B (1992). The trp gene is essential for a light-activated Ca2+ channel in Drosophila photoreceptors. Neuron 8(4): 643-651. Harteneck C, Gollasch M (2011). Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels. Curr Pharm Biotechnol 12(1): 35-41. He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL (2005). A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2. J Biol Chem 280(12): 10997-11006. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G (1999). Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397(6716): 259-263. Hruz PW, Mueckler MM (1999). Cysteine-scanning mutagenesis of transmembrane segment 7 of the GLUT1 glucose transporter. J Biol Chem 274(51): 36176-36180. Hu Y, Schilling WP (1995). Receptor-mediated activation of recombinant Trpl expressed in Sf9 insect cells. Biochem J 305 ( Pt 2): 605-611. Huang GN, Zeng W, Kim JY, Yuan JP, Han L, Muallem S, et al. (2006). STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat Cell Biol 8(9): 1003-1010. Humphrey W, Dalke A, Schulten K (1996). VMD: visual molecular dynamics. J Mol Graph 14(1): 33-38, 27-38. Jammes F, Hu HC, Villiers F, Bouten R, Kwak JM (2011). Calcium-permeable channels in plant cells. FEBS J 278(22): 4262-4276. Kim MS, Lee KP, Yang D, Shin DM, Abramowitz J, Kiyonaka S, et al. (2011). Genetic and pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects secretory epithelia from Ca2+-dependent toxicity. Gastroenterology 140(7): 2107-2115, 2115 e2101-2104.
104
Kiyonaka S, Kato K, Nishida M, Mio K, Numaga T, Sawaguchi Y, et al. (2009). Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci U S A 106(13): 5400-5405. Kiyonaka S, Kato K, Nishida M, Mori Y (2010). [Pharmacological properties of novel TRPC channel inhibitors]. Yakugaku Zasshi 130(3): 303-311. Kurz LL, Zuhlke RD, Zhang HJ, Joho RH (1995). Side-chain accessibilities in the pore of a K+ channel probed by sulfhydryl-specific reagents after cysteine-scanning mutagenesis. Biophys J 68(3): 900-905. Kwan HY, Huang Y, Yao X (2006). Protein kinase C can inhibit TRPC3 channels indirectly via stimulating protein kinase G. J Cell Physiol 207(2): 315-321. Law M, Morales JL, Mottram LF, Iyer A, Peterson BR, August A (2011). Structural requirements for the inhibition of calcium mobilization and mast cell activation by the pyrazole derivative BTP2. Int J Biochem Cell Biol 43(8): 1228-1239. Lemonnier L, Trebak M, Putney JW, Jr. (2008). Complex regulation of the TRPC3, 6 and 7 channel subfamily by diacylglycerol and phosphatidylinositol-4,5-bisphosphate. Cell Calcium 43(5): 506-514. Lewis RS (2001). Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19: 497-521. Lewis RS (2007). The molecular choreography of a store-operated calcium channel. Nature 446(7133): 284-287. Leypold BG, Yu CR, Leinders-Zufall T, Kim MM, Zufall F, Axel R (2002). Altered sexual and social behaviors in trp2 mutant mice. Proc Natl Acad Sci U S A 99(9): 6376-6381. Li J, McKeown L, Ojelabi O, Stacey M, Foster R, O'Regan D, et al. (2011). Nanomolar potency and selectivity of a Ca(2) release-activated Ca(2) channel inhibitor against store-operated Ca(2) entry and migration of vascular smooth muscle cells. Br J Pharmacol 164(2): 382-393. Li Z, Lu J, Xu P, Xie X, Chen L, Xu T (2007). Mapping the interacting domains of STIM1 and Orai1 in Ca2+ release-activated Ca2+ channel activation. J Biol Chem 282(40): 29448-29456. Liao Y, Erxleben C, Abramowitz J, Flockerzi V, Zhu MX, Armstrong DL, et al. (2008). Functional interactions among Orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channels. Proc Natl Acad Sci U S A 105(8): 2895-2900. Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L (2007). Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci U S A 104(11): 4682-4687. Liao Y, Plummer NW, George MD, Abramowitz J, Zhu MX, Birnbaumer L (2009). A role for Orai in TRPC-mediated Ca2+ entry suggests that a TRPC:Orai complex may mediate store and receptor operated Ca2+ entry. Proc Natl Acad Sci U S A 106(9): 3202-3206. Lievremont JP, Bird GS, Putney JW, Jr. (2005). Mechanism of inhibition of TRPC cation channels by 2-aminoethoxydiphenylborane. Mol Pharmacol 68(3): 758-762. Lis A, Peinelt C, Beck A, Parvez S, Monteilh-Zoller M, Fleig A, et al. (2007). CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr Biol 17(9): 794-800. Liu CH, Wang T, Postma M, Obukhov AG, Montell C, Hardie RC (2007a). In vivo identification and manipulation of the Ca2+ selectivity filter in the Drosophila transient receptor potential channel. J Neurosci 27(3): 604-615. Liu X, Cheng KT, Bandyopadhyay BC, Pani B, Dietrich A, Paria BC, et al. (2007b). Attenuation of store-operated Ca2+ current impairs salivary gland fluid secretion in TRPC1(-/-) mice. Proc Natl Acad Sci U S A 104(44): 17542-17547. Luik RM, Wang B, Prakriya M, Wu MM, Lewis RS (2008). Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature 454(7203): 538-542. Machaca K (2011). Ca(2+) signaling, genes and the cell cycle. Cell Calcium 49(5): 323-330.
105
Marumo M, Suehiro A, Kakishita E, Groschner K, Wakabayashi I (2001). Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry. Thromb Res 104(5): 353-360. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K (1997). 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. J Biochem 122(3): 498-505. McNally BA, Somasundaram A, Yamashita M, Prakriya M (2012). Gated regulation of CRAC channel ion selectivity by STIM1. Nature. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, et al. (1990). SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271(2): 515-522. Minke B (2010). The history of the Drosophila TRP channel: the birth of a new channel superfamily. J Neurogenet 24(4): 216-233. Minke B, Wu C, Pak WL (1975). Induction of photoreceptor voltage noise in the dark in Drosophila mutant. Nature 258(5530): 84-87. Mio K, Ogura T, Hara Y, Mori Y, Sato C (2005). The non-selective cation-permeable channel TRPC3 is a tetrahedron with a cap on the large cytoplasmic end. Biochem Biophys Res Commun 333(3): 768-777. Mio K, Ogura T, Kiyonaka S, Hiroaki Y, Tanimura Y, Fujiyoshi Y, et al. (2007). The TRPC3 channel has a large internal chamber surrounded by signal sensing antennas. J Mol Biol 367(2): 373-383. Moiseenkova-Bell V, Wensel TG (2011). Functional and structural studies of TRP channels heterologously expressed in budding yeast. Adv Exp Med Biol 704: 25-40. Montell C (2001). Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci STKE 2001(90): re1. Montell C, Rubin GM (1989). Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 2(4): 1313-1323. Moran MM, McAlexander MA, Biro T, Szallasi A (2011). Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10(8): 601-620. Muik M, Fahrner M, Derler I, Schindl R, Bergsmann J, Frischauf I, et al. (2009). A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 Channels. J Biol Chem 284(13): 8421-8426. Muik M, Frischauf I, Derler I, Fahrner M, Bergsmann J, Eder P, et al. (2008). Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J Biol Chem 283(12): 8014-8022. Nakayama H, Wilkin BJ, Bodi I, Molkentin JD (2006). Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 20(10): 1660-1670. Ng SW, di Capite J, Singaravelu K, Parekh AB (2008). Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels. J Biol Chem 283(46): 31348-31355. Nilius B, Owsianik G (2011). The transient receptor potential family of ion channels. Genome Biol 12(3): 218. Nilius B, Owsianik G, Voets T, Peters JA (2007). Transient receptor potential cation channels in disease. Physiol Rev 87(1): 165-217. Nishida M, Kurose H (2008). Roles of TRP channels in the development of cardiac hypertrophy. Naunyn Schmiedebergs Arch Pharmacol 378(4): 395-406. Numaga T, Nishida M, Kiyonaka S, Kato K, Katano M, Mori E, et al. (2010). Ca2+ influx and protein scaffolding via TRPC3 sustain PKCbeta and ERK activation in B cells. J Cell Sci 123(Pt 6): 927-938. O'Neil RG, Heller S (2005). The mechanosensitive nature of TRPV channels. Pflugers Arch 451(1): 193-203.
106
Obermayer D, Glasnov TN, Kappe CO (2011). Microwave-assisted and continuous flow multistep synthesis of 4-(pyrazol-1-yl)carboxanilides. J Org Chem 76(16): 6657-6669. Obukhov AG, Nowycky MC (2005). A cytosolic residue mediates Mg2+ block and regulates inward current amplitude of a transient receptor potential channel. J Neurosci 25(5): 1234-1239. Okada T, Inoue R, Yamazaki K, Maeda A, Kurosaki T, Yamakuni T, et al. (1999). Molecular and functional characterization of a novel mouse transient receptor potential protein homologue TRP7. Ca(2+)-permeable cation channel that is constitutively activated and enhanced by stimulation of G protein-coupled receptor. J Biol Chem 274(39): 27359-27370. Ong HL, Cheng KT, Liu X, Bandyopadhyay BC, Paria BC, Soboloff J, et al. (2007). Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components. J Biol Chem 282(12): 9105-9116. Owsianik G, Talavera K, Voets T, Nilius B (2006). Permeation and selectivity of TRP channels. Annu Rev Physiol 68: 685-717. Padinjat R, Andrews S (2004). TRP channels at a glance. J Cell Sci 117(Pt 24): 5707-5709. Pak WL, Grossfield J, Arnold KS (1970). Mutants of the visual pathway of Drosophila melanogaster. Nature 227(5257): 518-520. Pang B, Shin DH, Park KS, Huh YJ, Woo J, Zhang YH, et al. (2011). Differential pathways for calcium influx activated by concanavalin A and CD3 stimulation in Jurkat T cells. Pflugers Arch. Parekh AB (2010). Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 9(5): 399-410. Parekh AB, Putney JW, Jr. (2005). Store-operated calcium channels. Physiol Rev 85(2): 757-810. Park CY, Hoover PJ, Mullins FM, Bachhawat P, Covington ED, Raunser S, et al. (2009). STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 136(5): 876-890. Poteser M, Graziani A, Rosker C, Eder P, Derler I, Kahr H, et al. (2006). TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J Biol Chem 281(19): 13588-13595. Poteser M, Schleifer H, Lichtenegger M, Schernthaner M, Stockner T, Kappe CO, et al. (2011). PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes. Proc Natl Acad Sci U S A 108(26): 10556-10561. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG (2006). Orai1 is an essential pore subunit of the CRAC channel. Nature 443(7108): 230-233. Putney JW, Jr. (2004). The enigmatic TRPCs: multifunctional cation channels. Trends Cell Biol 14(6): 282-286. Putney JW, Jr. (1986). A model for receptor-regulated calcium entry. Cell Calcium 7(1): 1-12. Quintana A, Griesemer D, Schwarz EC, Hoth M (2005). Calcium-dependent activation of T-lymphocytes. Pflugers Arch 450(1): 1-12. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, et al. (2005). TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37(7): 739-744. Rosker C, Graziani A, Lukas M, Eder P, Zhu MX, Romanin C, et al. (2004). Ca(2+) signaling by TRPC3 involves Na(+) entry and local coupling to the Na(+)/Ca(2+) exchanger. J Biol Chem 279(14): 13696-13704. Salido GM, Sage SO, Rosado JA (2009). TRPC channels and store-operated Ca(2+) entry. Biochim Biophys Acta 1793(2): 223-230. Salmon MD, Ahluwalia J (2010). Discrimination between receptor- and store-operated Ca(2+) influx in human neutrophils. Cell Immunol 265(1): 1-5.
107
Schindl R, Bergsmann J, Frischauf I, Derler I, Fahrner M, Muik M, et al. (2008). 2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size. J Biol Chem 283(29): 20261-20267. Schindl R, Romanin C (2007). Assembly domains in TRP channels. Biochem Soc Trans 35(Pt 1): 84-85. Shi J, Takahashi S, Jin XH, Li YQ, Ito Y, Mori Y, et al. (2007). Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293 cells. Br J Pharmacol 152(1): 122-131. Singh BB, Zheng C, Liu X, Lockwich T, Liao D, Zhu MX, et al. (2001). Trp1-dependent enhancement of salivary gland fluid secretion: role of store-operated calcium entry. FASEB J 15(9): 1652-1654. Sinkins WG, Goel M, Estacion M, Schilling WP (2004). Association of immunophilins with mammalian TRPC channels. J Biol Chem 279(33): 34521-34529. Smyth JT, Dehaven WI, Bird GS, Putney JW, Jr. (2008). Ca2+-store-dependent and -independent reversal of Stim1 localization and function. J Cell Sci 121(Pt 6): 762-772. Smyth JT, DeHaven WI, Bird GS, Putney JW, Jr. (2007). Role of the microtubule cytoskeleton in the function of the store-operated Ca2+ channel activator STIM1. J Cell Sci 120(Pt 21): 3762-3771. Steinckwich N, Frippiat JP, Stasia MJ, Erard M, Boxio R, Tankosic C, et al. (2007). Potent inhibition of store-operated Ca2+ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2. J Leukoc Biol 81(4): 1054-1064. Stowers L, Holy TE, Meister M, Dulac C, Koentges G (2002). Loss of sex discrimination and male-male aggression in mice deficient for TRP2. Science 295(5559): 1493-1500. Su Z, Anishkin A, Kung C, Saimi Y (2011). The core domain as the force sensor of the yeast mechanosensitive TRP channel. J Gen Physiol 138(6): 627-640. Sweeney ZK, Minatti A, Button DC, Patrick S (2009). Small-molecule inhibitors of store-operated calcium entry. ChemMedChem 4(5): 706-718. Takahashi Y, Murakami M, Watanabe H, Hasegawa H, Ohba T, Munehisa Y, et al. (2007). Essential role of the N-terminus of murine Orai1 in store-operated Ca2+ entry. Biochem Biophys Res Commun 356(1): 45-52. Tiruppathi C, Minshall RD, Paria BC, Vogel SM, Malik AB (2002). Role of Ca2+ signaling in the regulation of endothelial permeability. Vascul Pharmacol 39(4-5): 173-185. Tominaga M (2007). The Role of TRP Channels in Thermosensation TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. edn. Taylor & Francis Group, LLC: Boca Raton FL. Trebak M (2010). The puzzling role of TRPC3 channels in motor coordination. Pflugers Arch 459(3): 369-375. Trebak M, Bird GS, McKay RR, Putney JW, Jr. (2002). Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem 277(24): 21617-21623. Trebak M, Hempel N, Wedel BJ, Smyth JT, Bird GS, Putney JW, Jr. (2005). Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712. Mol Pharmacol 67(2): 558-563. Trebak M, St JBG, McKay RR, Birnbaumer L, Putney JW, Jr. (2003a). Signaling mechanism for receptor-activated canonical transient receptor potential 3 (TRPC3) channels. J Biol Chem 278(18): 16244-16252. Trebak M, Vazquez G, Bird GS, Putney JW, Jr. (2003b). The TRPC3/6/7 subfamily of cation channels. Cell Calcium 33(5-6): 451-461. Trevillyan JM, Chiou XG, Chen YW, Ballaron SJ, Sheets MP, Smith ML, et al. (2001). Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds. J Biol Chem 276(51): 48118-48126. Tytgat J (1994). Mutations in the P-region of a mammalian potassium channel (RCK1): a comparison with the Shaker potassium channel. Biochem Biophys Res Commun 203(1): 513-518.
108
Uniprot (2012). Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40(Database issue): D71-75. Varnai P, Hunyady L, Balla T (2009). STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 30(3): 118-128. Vazquez G, Lievremont JP, St JBG, Putney JW, Jr. (2001). Human Trp3 forms both inositol trisphosphate receptor-dependent and receptor-independent store-operated cation channels in DT40 avian B lymphocytes. Proc Natl Acad Sci U S A 98(20): 11777-11782. Vazquez G, Wedel BJ, Trebak M, St John Bird G, Putney JW, Jr. (2003). Expression level of the canonical transient receptor potential 3 (TRPC3) channel determines its mechanism of activation. J Biol Chem 278(24): 21649-21654. Venkatachalam K, Zheng F, Gill DL (2003). Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem 278(31): 29031-29040. Vig M, Beck A, Billingsley JM, Lis A, Parvez S, Peinelt C, et al. (2006a). CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr Biol 16(20): 2073-2079. Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, et al. (2008). Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 9(1): 89-96. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, et al. (2006b). CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312(5777): 1220-1223. Voets T, Janssens A, Droogmans G, Nilius B (2004). Outer pore architecture of a Ca2+-selective TRP channel. J Biol Chem 279(15): 15223-15230. Watanabe H, Takahashi R, Zhang XX, Kakizawa H, Hayashi H, Ohno R (1996). Inhibition of agonist-induced Ca2+ entry in endothelial cells by myosin light-chain kinase inhibitor. Biochem Biophys Res Commun 225(3): 777-784. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ (2009). Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics 25(9): 1189-1191. Watson JD, Crick FH (1953). The structure of DNA. Cold Spring Harb Symp Quant Biol 18: 123-131. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, et al. (2005). A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308(5729): 1801-1804. Wolstenholme AJ, Williamson SM, Reaves BJ (2011). TRP channels in parasites. Adv Exp Med Biol 704: 359-371. Woodard GE, Lopez JJ, Jardin I, Salido GM, Rosado JA (2010). TRPC3 regulates agonist-stimulated Ca2+ mobilization by mediating the interaction between type I inositol 1,4,5-trisphosphate receptor, RACK1, and Orai1. J Biol Chem 285(11): 8045-8053. Xu SZ, Zeng F, Boulay G, Grimm C, Harteneck C, Beech DJ (2005). Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br J Pharmacol 145(4): 405-414. Yildirim E, Kawasaki BT, Birnbaumer L (2005). Molecular cloning of TRPC3a, an N-terminally extended, store-operated variant of the human C3 transient receptor potential channel. Proc Natl Acad Sci U S A 102(9): 3307-3311. Yuan JP, Zeng W, Dorwart MR, Choi YJ, Worley PF, Muallem S (2009). SOAR and the polybasic STIM1 domains gate and regulate Orai channels. Nat Cell Biol 11(3): 337-343. Zeng W, Yuan JP, Kim MS, Choi YJ, Huang GN, Worley PF, et al. (2008). STIM1 gates TRPC channels, but not Orai1, by electrostatic interaction. Mol Cell 32(3): 439-448. Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, et al. (2005). STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 437(7060): 902-905.
109
Zhu X, Chu PB, Peyton M, Birnbaumer L (1995). Molecular cloning of a widely expressed human homologue for the Drosophila trp gene. FEBS Lett 373(3): 193-198. Zhu X, Jiang M, Birnbaumer L (1998). Receptor-activated Ca2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. Evidence for a non-capacitative Ca2+ entry. J Biol Chem 273(1): 133-142. Zhu X, Jiang M, Peyton M, Boulay G, Hurst R, Stefani E, et al. (1996). trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. Cell 85(5): 661-671. Zitt C, Halaszovich CR, Luckhoff A (2002). The TRP family of cation channels: probing and advancing the concepts on receptor-activated calcium entry. Prog Neurobiol 66(4): 243-264.